Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
IMP3 encodes the human homolog of the yeast Imp3 protein. Additionally we are shipping IMP3 Proteins (8) and IMP3 Kits (2) and many more products for this protein.
Showing 10 out of 80 products:
Cow (Bovine) Polyclonal IMP3 Primary Antibody for IHC, WB - ABIN2779134
Ma, Jin, Liu, Yang, Zheng, Zhang, Miao, Chen: [Comparison of 3 hand-carried ultrasound devices with comprehensive echocardiographic devices in elderly cardiac inpatient examinations]. in Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation 2008
Show all 2 Pubmed References
Human Polyclonal IMP3 Primary Antibody for ELISA, WB - ABIN4325734
Walter, Prasad, Lu, Quinlan, Edmiston, Khan: IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. in Human pathology 2009
our study found that IMP3 (show IGF2BP3 Antibodies) expression was higher in the ovarian clear cell carcinoma than the high grade serous and endometrioid subtypes
IMP3 (show IGF2BP3 Antibodies) expression in uterine leiomyosarcoma could be a marker of a poor prognosis.
IMP3 (show IGF2BP3 Antibodies) positive pT1 (show ZNF77 Antibodies) EAC (show CYLD Antibodies) revealed higher levels of lymph node metastases.
IMP3 (show IGF2BP3 Antibodies) is a strong prognostic factor in non-neuroendocrine brain metastases and in particular in patients with adenocarcinoma metastases.IMP3 expression is associated with poor prognosis in patients with non-small cell lung cancer brain metastases.
Study found IMP3 (show IGF2BP3 Antibodies) frequently overexpressed in many human neoplasms and show significant associations with adverse tumor features in esophageal adenocarcinomas and cancers of the urinary bladder, lung, stomach, and pancreas.
In this study, IMP3 (show IGF2BP3 Antibodies) at the nodal site resulted to be associated with low progression-free survival in small-intestine neuroendocrine neoplasms, independently of the Ki-67 (show MKI67 Antibodies) index.
IMP3 (show IGF2BP3 Antibodies) may contribute to the aggressive behavior of metaplastic breast carcinoma , and that this expression could potentially be a prognostic marker
These findings suggest that IMP3 (show IGF2BP3 Antibodies) expression has prognostic value as a biomarker for chemosensitivity and overall survival in triple negative breast cancer
This study establishes p65 (show GORASP1 Antibodies) as a novel target of IMP3 (show IGF2BP3 Antibodies) in increasing glioma cell migration and underscores the significance of IMP3 (show IGF2BP3 Antibodies)-p65 (show GORASP1 Antibodies) feedback loop for therapeutic targeting in GBM.
IMP3 (show IGF2BP3 Antibodies) has a similar specificity, but a better sensitivity, intensity, and extent of reactivity in comparison with AMACR (show AMACR Antibodies), and may be used as an alternative to AMACR (show AMACR Antibodies), in support of the diagnosis of BE-dysplasia and EAC (show CYLD Antibodies)
Imp3 (show SPPL2A Antibodies) as a key regulator of stem-like tumorigenic characteristics in osteosarcoma cells
This gene encodes the human homolog of the yeast Imp3 protein. The protein localizes to the nucleoli and interacts with the U3 snoRNP complex. The protein contains an S4 domain.
U3 small nucleolar ribonucleoprotein protein IMP3
, U3 snoRNP protein 3 homolog
, U3 snoRNP protein IMP3
, IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast)
, IMP3, U3 small nucleolar ribonucleoprotein, homolog
, IMP3, U3 small nucleolar ribonucleoprotein L homeolog